VAERS reports by lot

GSK Varicella/Shingles lot GG2GA: VAERS reports

47 VAERS reports list lot GG2GA as a GSK Varicella/Shingles vaccine, received between 2018-10-16 and 2021-11-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
47
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)8436%
Injection-site / Local reaction4218%
Neurological2711%
Musculoskeletal219%
Gastrointestinal209%
Dermatological (non-injection-site)188%
Cardiac / Cardiovascular73%
Respiratory63%
Allergic / Anaphylactic52%
Psychiatric / Neuropsychiatric31%
Thrombotic / Hematological10%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Maryland5
Pennsylvania4
Ohio4
Kansas4
South Carolina3
California2
Oregon2
Texas2
New Mexico2
Washington2
Indiana2
Hawaii1

Reports by month received

2018-109
2018-1117
2018-128
2019-014
2019-022
2019-034
2019-041
2019-061
2021-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.